Pre-Evaluated Safe Human iPSC-Derived Neural Stem Cells Promote Functional Recovery after Spinal Cord Injury in Common Marmoset without Tumorigenicity

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Kobayashi, Yoshiomi ^a   Okada, Yohei ^a   Itakura, Go ^a   Iwai, Hiroki ^a   Nishimura, Soraya ^a   Yasuda, Akimasa ^a   Nori, Satoshi ^a   Hikishima, Keigo ^a,b   Konomi, Tsunehiko ^a   Fujiyoshi, Kanehiro ^c   Tsuji, Osahiko ^d   Toyama, Yoshiaki ^a   Yamanaka, Shinya ^e   Nakamura, Masaya ^a   Okano, Hideyuki ^a  

^a KEIO UNIVERSITY   (Japan)

^b CENTRAL INSTITUTE FOR EXPERIMENTAL ANIMALS   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION MURAYAMA MEDICAL CENTER   (Japan)

^d Saitama Social Insurance Hospital   (Japan)

^e KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II ALPHA; CD31 ANTIGEN; CILIARY NEUROTROPHIC FACTOR; KI 67 ANTIGEN; MESSENGER RNA; NEUROFILAMENT 200 PROTEIN; NEUROFILAMENT PROTEIN; NEUROTROPHIN 3; NEUROTROPHIN 4; OCTAMER TRANSCRIPTION FACTOR 4; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIORAL TEST; CALLITHRIX; CARCINOGENICITY; CELL ACTIVATION; CELL DIFFERENTIATION; CELL SURVIVAL; CONTROLLED STUDY; DEMYELINATION; FEMALE; FUNCTION TEST; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; MICROGLIA; MOLECULAR CLONING; MOLECULAR DYNAMICS; NERVE GROWTH; NERVE REGENERATION; NEURAL STEM CELL TRANSPLANTATION; NONHUMAN; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPINAL CORD INJURY;

ANIMALS; CALCITONIN GENE-RELATED PEPTIDE; CALLITHRIX; CELL DIFFERENTIATION; CELL SURVIVAL; CELL TRANSFORMATION, NEOPLASTIC; CELLS, CULTURED; CICATRIX; DEMYELINATING DISEASES; FEMALE; HAND STRENGTH; HUMANS; INDUCED PLURIPOTENT STEM CELLS; LOCOMOTION; MICROGLIA; MOTOR NEURONS; NEOVASCULARIZATION, PHYSIOLOGIC; NERVE GROWTH FACTORS; NERVE REGENERATION; NEURAL STEM CELLS; RECOVERY OF FUNCTION; SPINAL CORD; SPINAL CORD INJURIES; STEM CELL TRANSPLANTATION;

ANIMALIA; CALLITHRIX JACCHUS; MURINAE; PRIMATES; RODENTIA;

EID: 84871657149     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0052787     Document Type: Article

References (71)

1. Gage FH, (2000) Mammalian neural stem cells. Science 287: 1433-1438.
2. Bjorklund A, Lindvall O, (2000) Cell replacement therapies for central nervous system disorders. Nature Neuroscience 3: 537-544.
3. Lindvall O, Kokaia Z, (2006) Stem cells for the treatment of neurological disorders. Nature 441: 1094-1096.
4. Ogawa Y, Sawamoto K, Miyata T, Miyao S, Watanabe M, et al. (2002) Transplantation of in vitro-expanded fetal neural progenitor cells results in neurogenesis and functional recovery after spinal cord contusion injury in adult rats. Journal of Neuroscience Research 69: 925-933.
5. Iwanami A, Kaneko S, Nakamura M, Kanemura Y, Mori H, et al. (2005) Transplantation of human neural stem cells for spinal cord injury in primates. Journal of Neuroscience Research 80: 182-190.
6. Takahashi K, Yamanaka S, (2006) Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126: 663-676.
7. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, et al. (2007) Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
8. Tsuji O, Miura K, Okada Y, Fujiyoshi K, Mukaino M, et al. (2010) From the Cover: Therapeutic potential of appropriately evaluated safe-induced pluripotent stem cells for spinal cord injury. Proceedings of the National Academy of Sciences of the United States of America 107: 12704-12709.
9. Nori S, Okada Y, Yasuda A, Tsuji O, Takahashi Y, et al. (2011) Grafted human-induced pluripotent stem-cell-derived neurospheres promote motor functional recovery after spinal cord injury in mice. Proceedings of the National Academy of Sciences of the United States of America 108: 16825-16830.
10. Okada Y, Matsumoto A, Shimazaki T, Enoki R, Koizumi A, et al. (2008) Spatiotemporal recapitulation of central nervous system development by murine embryonic stem cell-derived neural stem/progenitor cells. STEM CELLS 26: 3086-3098.
11. Okada Y, Shimazaki T, Sobue G, Okano H, (2004) Retinoic-acid-concentration-dependent acquisition of neural cell identity during in vitro differentiation of mouse embryonic stem cells. Developmental biology 275: 124-142.
12. Imaizumi Y, Okada Y, Akamatsu W, Koike M, Kuzumaki N, et al. (2012) Mitochondrial dysfunction associated with increased oxidative stress and alpha-synuclein accumulation in PARK2 iPSC-derived neurons and postmortem brain tissue. Molecular brain 5: 35.
13. Nagai T, Ibata K, Park ES, Kubota M, Mikoshiba K, et al. (2002) A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nature Biotechnology 20: 87-90.
14. Iwanami A, Yamane J, Katoh H, Nakamura M, Momoshima S, et al. (2005) Establishment of graded spinal cord injury model in a nonhuman primate: the common marmoset. Journal of Neuroscience Research 80: 172-181.
15. Yamane J, Nakamura M, Iwanami A, Sakaguchi M, Katoh H, et al. (2010) Transplantation of galectin-1-expressing human neural stem cells into the injured spinal cord of adult common marmosets. Journal of Neuroscience Research 88: 1394-1405.
16. Kitamura K, Fujiyoshi K, Yamane J-I, Toyota F, Hikishima K, et al. (2011) Human hepatocyte growth factor promotes functional recovery in primates after spinal cord injury. PloS one 6: e27706.
17. Ohta K, Fujimura Y, Nakamura M, Watanabe M, Yato Y, (1999) Experimental study on MRI evaluation of the course of cervical spinal cord injury. Spinal cord 37: 580-584.
18. Metz GA, Curt A, van de Meent H, Klusman I, Schwab ME, et al. (2000) Validation of the weight-drop contusion model in rats: a comparative study of human spinal cord injury. Journal of neurotrauma 17: 1-17.
19. Fujiyoshi K, Tsuji O, Konomi T, Hikishima K, Yamada M, et al. (2011) q-space MR imaging depict demyelination after spinal cord injury in non-human primate. [abstract] 41st Annual Meeting Neuroscience 2011, Washington, DC 160.117/CC116.
20. Fujiyoshi K, Tsuji O, Hikishima K, Yamada M, Kitamura K, et al. (2009) q-space MR imaging depict demylination after spinal cord injury in non-human primate. [abstract] 39th Annual Meeting Neuroscience 2009, Chicago: 542.549/S546.
21. Cory DG, Garroway AN, (1990) Measurement of translational displacement probabilities by NMR: an indicator of compartmentation. Magnetic resonance in medicine 14: 435-444.
22. Callaghan PT, Coy A, Macgowan D, Packer KJ, Zelaya FO, (1991) Diffraction-Like Effects in Nmr Diffusion Studies of Fluids in Porous Solids. Nature 351: 467-469.
23. Nakamura Y, Yamamoto M, Oda E, Yamamoto A, Kanemura Y, et al. (2003) Expression of tubulin beta II in neural stem/progenitor cells and radial fibers during human fetal brain development. Laboratory investigation 83: 479-489.
24. Kanemura Y, Mori H, Kobayashi S, Islam O, Kodama E, et al. (2002) Evaluation of in vitro proliferative activity of human fetal neural stem/progenitor cells using indirect measurements of viable cells based on cellular metabolic activity. Journal of Neuroscience Research 69: 869-879.
25. Loh YH, Wu Q, Chew JL, Vega VB, Zhang W, et al. (2006) The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nature genetics 38: 431-440.
26. Krenz NR, Weaver LC, (1998) Sprouting of primary afferent fibers after spinal cord transection in the rat. Neuroscience 85: 443-458.
27. Krenz NR, Meakin SO, Krassioukov AV, Weaver LC, (1999) Neutralizing intraspinal nerve growth factor blocks autonomic dysreflexia caused by spinal cord injury. The Journal of Neuroscience 19: 7405-7414.
28. Hofstetter CP, Holmstrom NA, Lilja JA, Schweinhardt P, Hao J, et al. (2005) Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nature Neuroscience 8: 346-353.
29. Bradbury EJ, Khemani S, Von R, King, Priestley JV, et al. (1999) NT-3 promotes growth of lesioned adult rat sensory axons ascending in the dorsal columns of the spinal cord. The European journal of neuroscience 11: 3873-3883.
30. Shang A-J, Hong S-Q, Xu Q, Wang H-Y, Yang Y, et al. (2011) NT-3-secreting human umbilical cord mesenchymal stromal cell transplantation for the treatment of acute spinal cord injury in rats. Brain research 1391: 102-113.
31. McTigue DM, Horner PJ, Stokes BT, Gage FH, (1998) Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. The Journal of Neuroscience 18: 5354-5365.
32. Leung DW, Cachianes G, Kuang WJ, Goeddel DV, Ferrara N, (1989) Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309.
33. Scivoletto G, Di Donna V, (2009) Prediction of walking recovery after spinal cord injury. Brain research bulletin 78: 43-51.
34. van Middendorp JJ, Hosman AJ, Donders ART, Pouw MH, Ditunno JF, et al. (2011) A clinical prediction rule for ambulation outcomes after traumatic spinal cord injury: a longitudinal cohort study. Lancet.
35. Fehlings MG, Vawda R, (2011) Cellular treatments for spinal cord injury: the time is right for clinical trials. Neurotherapeutics 8: 704-720.
36. Devivo MJ, (2012) Epidemiology of traumatic spinal cord injury: trends and future implications. Spinal cord 50: 365-372.
37. Nakamura M, Houghtling RA, MacArthur L, Bayer BM, Bregman BS, (2003) Differences in cytokine gene expression profile between acute and secondary injury in adult rat spinal cord. Exp Neurol 184: 313-325.
38. Okada S, Ishii K, Yamane J, Iwanami A, Ikegami T, et al. (2005) In vivo imaging of engrafted neural stem cells: its application in evaluating the optimal timing of transplantation for spinal cord injury. The FASEB journal 19: 1839-1841.
39. Okano H, (2002) Stem cell biology of the central nervous system. Journal of Neuroscience Research 69: 698-707.
40. Okano H, (2002) Neural stem cells: progression of basic research and perspective for clinical application. The Keio journal of medicine 51: 115-128.
41. Dhodapkar KM, Feldman D, Matthews P, Radfar S, Pickering R, et al. (2010) Natural immunity to pluripotency antigen OCT4 in humans. Proceedings of the National Academy of Sciences of the United States of America 107: 8718-8723.
42. Guo Y, Liu S, Wang P, Zhao S, Wang F, et al. (2011) Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas. Histopathology 59: 763-775.
43. Schuldiner M, Itskovitz-Eldor J, Benvenisty N, (2003) Selective ablation of human embryonic stem cells expressing a "suicide" gene. STEM CELLS 21: 257-265.
44. Eiges R, Schuldiner M, Drukker M, Yanuka O, Itskovitz-Eldor J, et al. (2001) Establishment of human embryonic stem cell-transfected clones carrying a marker for undifferentiated cells. Current biology 11: 514-518.
45. Fujimoto Y, Abematsu M, Falk A, Tsujimura K, Sanosaka T, et al. (2012) Treatment of a mouse model of spinal cord injury by transplantation of human induced pluripotent stem cell-derived long-term self-renewing neuroepithelial-like stem cells. STEM CELLS 30: 1163-1173.
46. Bradbury EJ, McMahon SB, (2006) Spinal cord repair strategies: why do they work? Nature reviews Neuroscience 7: 644-653.
47. Lemon RN, (2008) Descending pathways in motor control. Annual review of neuroscience 31: 195-218.
48. Ishii K, Nakamura M, Dai H, Finn TP, Okano H, et al. (2006) Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury. Journal of Neuroscience Research 84: 1669-1681.
49. Sundberg M, Skottman H, Suuronen R, Narkilahti S, (2010) Production and isolation of NG2+ oligodendrocyte precursors from human embryonic stem cells in defined serum-free medium. Stem cell research 5: 91-103.
50. Kim HM, Hwang DH, Lee JE, Kim SU, Kim BG, (2009) Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PloS one 4: e4987.
51. Lee HJ, Kim KS, Park IH, Kim SU, (2007) Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model. PloS one 2: e156.
52. Martino G, Pluchino S, (2006) The therapeutic potential of neural stem cells. Nature reviews Neuroscience 7: 395-406.
53. Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, et al. (2003) Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature 422: 688-694.
54. Butovsky O, Koronyo-Hamaoui M, Kunis G, Ophir E, Landa G, et al. (2006) Glatiramer acetate fights against Alzheimer's disease by inducing dendritic-like microglia expressing insulin-like growth factor 1. Proceedings of the National Academy of Sciences of the United States of America 103: 11784-11789.
55. Kokaia Z, Martino G, Schwartz M, Lindvall O, (2012) Cross-talk between neural stem cells and immune cells: the key to better brain repair? Nature Neuroscience 15: 1078-1087.
56. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, et al. (2005) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. The Journal of Neuroscience 25: 4694-4705.
57. Yasuda A, Tsuji O, Shibata S, Nori S, Takano M, et al. (2011) Significance of remyelination by neural stem/progenitor cells transplanted into the injured spinal cord. STEM CELLS 29: 1983-1994.
58. Wernig M, Zhao JP, Pruszak J, Hedlund E, Fu D, et al. (2008) Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease. Proceedings of the National Academy of Sciences of the United States of America 105: 5856-5861.
59. Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, et al. (2007) Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 318: 1920-1923.
60. Okano H, Nakamura M, Yoshida K, Okada Y, Tsuji O, et al. (2012) Steps toward safe cell therapy using induced pluripotent stem cells. Circulation Research in press.
61. Wang W, Yang J, Liu H, Lu D, Chen X, et al. (2011) Rapid and efficient reprogramming of somatic cells to induced pluripotent stem cells by retinoic acid receptor gamma and liver receptor homolog 1. Proceedings of the National Academy of Sciences of the United States of America pp. 1-6.
62. Zhou H, Wu S, Joo JY, Zhu S, Han DW, et al. (2009) Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 4: 381-384.
63. Kim D, Kim CH, Moon JI, Chung YG, Chang MY, et al. (2009) Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 4: 472-476.
64. Shi Y, Do JT, Desponts C, Hahm HS, Scholer HR, et al. (2008) A combined chemical and genetic approach for the generation of induced pluripotent stem cells. Cell Stem Cell 2: 525-528.
65. Maherali N, Hochedlinger K, (2009) Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Current Biology 19: 1718-1723.
66. Jia F, Wilson KD, Sun N, Gupta DM, Huang M, et al. (2010) A nonviral minicircle vector for deriving human iPS cells. Nature Methods 7: 197-199.
67. Hu K, Yu J, Suknuntha K, Tian S, Montgomery K, et al. (2011) Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bone marrow and cord blood mononuclear cells. Blood 117: e109-e119.
68. Rhee Y-H, Ko J-Y, Chang M-Y, Yi S-H, Kim D, et al. (2011) Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. The Journal of clinical investigation pp. 1-10.
69. Yu J, Hu K, Smuga-Otto K, Tian S, Stewart R, et al. (2009) Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.
70. Yusa K, Rad R, Takeda J, Bradley A, (2009) Generation of transgene-free induced pluripotent mouse stem cells by the piggyBac transposon. Nature Methods 6: 363-369.
71. Kaji K, Norrby K, Paca A, Mileikovsky M, Mohseni P, et al. (2009) Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 458: 771-775.